| Institutions |
Authors |
Share |
|
Johnson & Johnson, United States of America (USA)
|
5.000000
|
0.16 |
|
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
|
4.000000
|
0.13 |
|
University Hospital Nantes (CHU de Nantes), France
|
4.000000
|
0.13 |
|
Toulouse University Hospital (CHU-Toulouse), France
|
2.000000
|
0.06 |
|
Erasmus MC Cancer Institute, Netherlands
|
2.000000
|
0.06 |
|
Amsterdam UMC, Netherlands
|
2.000000
|
0.06 |
|
Montpellier University Hospital, UM, France
|
1.000000
|
0.03 |
|
Hôpital Haut-Lévêque, France
|
1.000000
|
0.03 |
|
Institut de Cancérologie de Bourgogne, France
|
1.000000
|
0.03 |
|
Catholic University of Leuven (KU Leuven), Belgium
|
1.000000
|
0.03 |
|
Hôpital Saint-Louis, France
|
1.000000
|
0.03 |
|
CHU Caen, France
|
1.000000
|
0.03 |
|
Cytel Inc., United States of America (USA)
|
1.000000
|
0.03 |
|
Janssen Pharmaceutica, Belgium
|
1.000000
|
0.03 |
|
Janssen Vaccines and Prevention B.V., Netherlands
|
1.000000
|
0.03 |
|
Johnson & Johnson, UK, United Kingdom (UK)
|
1.000000
|
0.03 |
|
Centre Hospitalier Universitaire de Lille (CHU Lille), France
|
0.500000
|
0.02 |
|
University of Lille (UDL), France
|
0.500000
|
0.02 |
|
laboratoire Ischémie Reperfusion, Métabolisme et Inflammation Stérile en Transplantation (IRMETIST), France
|
0.500000
|
0.02 |
|
CHU de Poitiers, France
|
0.500000
|
0.02 |
